Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1475-1481

  Visalli, Melissa A ^a   Bajaksouzian, Saralee ^b   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; CLINAFLOXACIN; IMIPENEM; LEVOFLOXACIN; OFLOXACIN; SPARFLOXACIN; TROVAFLOXACIN;

ALCALIGENES; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; FLAVOBACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS STUTZERI; STENOTROPHOMONAS MALTOPHILIA;

EID: 0030845019     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1475     Document Type: Article

References (44)

1. Appelbaum, P. C., S. K. Spangler, and L. Sollenberger. 1986. Susceptibility of nonfermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and ccfpirome. J. Antimicrob. Chemother. 18:675-679.
2. Appelbaum, P. C., S. K. Spangler, and T. Tamarree. 1988. Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin. Chemotherapy (Basel) 34:40-45.
3. Appelbaum, P. C., J. Tamim, J. Stavitz, R. C. Aber, and G. A. Pankuch. 1982. Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics. Eur. J. Clin. Microbiol. 1:159-165.
4. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1997. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studios. Antimicrob. Agents Cnemother. 41:1073-1076.
5. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrob. Agents Chemother. 40:1973-1976.
6. Bergogne-Berezin, E., and M. L. Joly-Guillou. 1986. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 18(Suppl. E):35-39.
7. Bizet, C., E. Tekaia, and A. Philippon. 1993. In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven β-lactams. J. Antimicrob. Chemother. 32:907-910.
8. Cantón, E., J. Pemán, M. T. Jimenez, M. S. Ramón, and M. Gobernado, 1992. In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob. Agents Chemother. 36:558-565.
9. Cappelletty, D. M., and M. J. Rybak. 1996. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:677-683.
10. Child, J., J. Andrews, F. Boswell, N. Brenwald, and R. Wise. 1995. The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. J. Antimicrob. Chemother. 35:869-876.
11. Decré, D., G. Arlet, C. Danglot, J.-C. Lucet, G. Fournier, E. Bergogne-Bérézin, and A. Philippon. 1992. A β-lactamase-overproducing strain of Alcaligenes denitrificans subsp. xylosoxidans isolated from a case of meningitis. J. Antimicrob. Chemother. 30:769-779.
12. Decré, D., C. Benoit, M. L. Joly-Guillou, E. Bergogne-Berezin, and A. Bryskier. 1995. In vitro activity and bactericidal activity of levofloxacin (levx) alone or in combination with amikacin against Acinetobacter spp in comparison with ofloxacin (ofl) and ciprofloxacin (cip), abstr. E100, p. 103. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
13. Dholakia, N., K. V. I. Rolston, D. H. Ho, B. LeBlanc, and G. P. Bodey. 1994. Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones. Antimicrob. Agents Chemother. 38:848-852.
14. Eliopoulos, G. M., and R. C. Moellering, Jr. 1996. Antimicrobial combinations, p. 330-396. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
15. Fass, R. J., and J. Barnishan. 1980. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev. Infect. Dis. 2:841-853.
16. Fass, R. J., J. Barnishan, M. C. Solomon, and L. W. Ayers. 1996. In vitro activities of quinolones, β-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacteria. Antimicrob. Agents Chemother. 40:1412-1418.
17. Fu, K. P., S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthale. 1992. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin. Antimicrob. Agents Chemother. 36:860-866.
18. Gilligan, P. H. 1995. Pseudomonas and Burkholderia, p. 509-519. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
19. Glupczynski, Y., W. Hensen, J. Freney, and E. Yourrasowsky. 1988. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob. Agents Chemother. 32:276-278.
20. Gooding, B. G., and R. N. Jones. 1993. In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone. Antimicrob. Agents Chemother. 37:349-353.
21. Husson, M. O., D. Izard, L. Bouillet, and H. Leclerc. 1985. Comparative in-vitro activity of ciprofloxacin against non-fermenters. J. Antimicrob. Chemother. 15:457-462.
22. Joly-Guillou, M. L., and E. Bergogne-Bérézin. 1992. In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp. J. Antimicrob. Chemother. 29:466-468.
23. Khardori, N., A. Reuben, B. Rosenbaum, K. Rolston, and G. P. Bodey. 1990. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob. Agents Chemother. 34:1609-1610.
24. Lecso-Bornet, M., J. Pierre, D. Sarkis-Karam, S. Lubera, and E. Bergogne-Berezin. 1992. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob. Agents Chemother. 36:669-671.
25. Louie, A., A. L. Baltch, W. J. Ritz, and R. P. Smith. 1991. Comparative in vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD 131501) and reference antimicrobial agents. J. Antimicrob. Chemother. 27:793-799.
26. Mensah, K., A. Philippon, C. Richard, and P. Névot. 1990. Susceptibility of Alcaligenes denitrificans subspecies xylosoxidans to beta-lactam antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 9:405-409.
27. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
28. Neu, H. C., and N.-X. Chin. 1989. In vitro activity of S-ofloxacin. Antimicrob. Agents Chemother. 33:1105-1107.
29. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 38:2065-2072.
30. Raimondi, A., F. Moosdeen, and J. D. Williams. 1986. Antibiotic resistance pattern of Flavobacterium meningosepticum. Eur. J. Clin. Microbiol. Infect. Dis. 5:461-463.
31. Rolston, K. V. I., and G. P. Bodey. 1986. In vitro susceptibility of Acinetobacter species to various antimicrobial agents. Antimicrob. Agents Chemother. 30:769-770.
32. Rolston, K. V. I., D. H. Ho, B. LeBlanc, and G. P. Bodey. 1993. In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer. Antimicrob. Agents Chemother. 37:2504-2505.
33. Rolston, K. V. I., H. Nguyen, M. Messer, B. LeBlanc, D. H. Ho, and G. P. Bodey. 1990. In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients. Antimicrob. Agents Chemother. 34: 2263-2266.
34. Seifert, H., R. Baginski, A. Schulze, and G. Pulverer. 1993. Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agents Chemother. 37: 750-753.
35. Simor, A. E., L. Louie, and M. Louie. 1994. In vitro susceptibility of Acinetobacter baumannii to biapenem, piperacillin/tazobactam and thirteen other antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 13:521-523.
36. Smalley, D. L., V. R. Hansen, and V. S. Baselski. 1983. Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents. Antimicrob. Agents Chemother. 23:161-162.
37. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1994. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against 489 anaerobes. Antimicrob. Agents Chemother. 38:2471-2476.
38. Spangler, S. K., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob. Agents Chemother. 40:772-775.
39. Tanaka, M., M. Otsuki, T. Une, and T. Nishino. 1990. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. J. Antimicrob. Chemother. 26:659-666.
40. Vartivarian, S., E. Anaissie, G. Bodey, H. Sprigg, and K. Rolston. 1994. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38: 624-627.
41. Visser, M. R., M. Rozenberg-Arska, H. Beumer, I. M. Hoepelman, and J. Verhoef. 1991. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Antimicrob. Agents Chemother. 35:858-868.
42. von Graevenitz, A. 1995. Acinetobocter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria, p. 520-532. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
43. von Graevenitz, A., and C. Bucher. 1982. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans. Infection 10:293-298.
44. Wise, R., J. P. Ashby, and J. M. Andrews. 1988. In vitro activity of PD 127,391, an enhanced-spectrum quinolone. Antimicrob. Agents Chemother. 32:1251-1256.